2024 Midwest Radiation Oncology Symposium: Unlocking Innovations in Cancer Care – AI in Radiation Oncology
Join us at the forefront of Artificial Intelligence in Radiation Oncology!
We are thrilled to announce our upcoming symposium dedicated to the dynamic convergence of AI and Radiation Oncology, where cutting-edge technologies meet the intricacies of cancer treatment.
This symposium aims to bring together the brilliant minds of physicians and physicists, fostering an interdisciplinary dialogue that explores the immense potential of AI in revolutionizing radiation oncology.
Our primary objectives are to delve into the latest advancements, share groundbreaking research, and discuss collaborative strategies for integrating AI seamlessly into clinical practices.
This symposium is a unique opportunity to explore the intersection of medicine and technology.
Don't miss your chance to be part of a transformative event that accelerates the future of cancer care. Join us as we embark on a journey toward redefining the landscape of AI in Radiation Oncology.
Symposium Objectives
At the conclusion of this activity, the participants should be better able to:
- Explore the transformative role of technology in modern oncology, encompassing Artificial Intelligence integration in radiotherapy practices, advancements in medical image analysis, and its impact on personalized treatment approaches.
- Investigate innovative radiation techniques such as proton FLASH and stereotactic body radiotherapy (SBRT), focusing on mechanisms of action and their potential applications across different cancer types.
- Examine strategies for effective patient communication and education, including eLearning, simulation-based training, and the role of global health rotations in residency programs for fostering cultural competency and enhancing patient care.
- Evaluate the evolving landscape of cancer diagnosis, with a spotlight on the application of AI in brain tumor detection and characterization.
- Discuss contemporary approaches to the management of various malignancies, including early-stage non-small cell lung cancer, renal masses, and prostate cancer risk stratification through radiomics.
- Explore the multidisciplinary nature of cancer treatment, with insights into the roles and responsibilities of healthcare professionals in delivering comprehensive care at community cancer centers.
- Identify current and emerging surgical and radiotherapy strategies for soft tissue sarcoma management.
- Review the latest advancements in the treatment of hepatocellular carcinoma, including Y90 radioembolization, SBRT, and immunotherapy.
General Information
Friday-Saturday, Aug. 23-24
Registration Information
General Registration
| By July 26 | After July 26 | |
| Aug. 23-24 | $100 | $150 |
| Aug. 23 Only | $65 | $100 |
| Aug. 24 Only | $65 | $100 |
Students/Fellows/Residents
Students, fellows, and residents may attend this symposium for free.
The deadline to register is Aug. 9, 2024.
If you need assistance with online registration, please call our Registration Office at 402-559-5929.
Cancel/Refund Policy
If you need to cancel your registration, please email conted@unmc.edu no later than Aug. 9, 2024. There is a $25 processing fee for cancellations made by Aug. 9. Cancellations made after this date and registrants who fail to attend are responsible for the full registration fee.
Symposium Director
Professor and Vice Chair of Research, Department of Radiation Oncology, UNMC
Questions?
Director, Educational Programs, UNMC Center for Continuing Education
